SP
Santhera Pharmaceuticals Holding AG
SPHDF · OTC
$19.79 +0.00% (+$0.00)
Market Cap CHF 241.4M
P/E Ratio -
Div. Yield -
ROE 321.07%
Bulios Fair Price
$28.78
45.4% upside
Current Price
$19.79
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SPHDF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
56 /100
Fair P/S 3.13x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 117.81%
EPS growth N/A
FCF growth N/A
Profitability
5 /100
Weak Gross margin 18.74%
Net margin 63.79%
Op. margin 48.99%
Quality
6 /100
Poor ROIC 34.62%
ROE 321.07%
ROA 33.25%
Debt
25 /100
High Current ratio 1.29x
Int. coverage -3.27x
Debt/Equity N/A
Stability
13 /100
Unstable Beta -0.28x
Rev. volatility 735.39%
EPS volatility 158.47%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SPHDF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Orlando Oliveira
Employees
78
Headquarters
Pratteln